Oncology Ablation Market Poised to Hit $2.35 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Oncology Ablation Market Size Growth Forecast: What to Expect by 2025?
There has been swift expansion in the oncology ablation market size in the past few years. The market's worth is projected to rise from $1.3 billion in 2024 to $1.46 billion in 2025, experiencing a compound annual growth rate (CAGR) of 12.9%. The growth during the historic period can be credited to factors such as the rise in cancer cases, preference towards minimally invasive ablation methods, heightened spending on healthcare, clearance for new ablation equipment and technologies, enhanced cancer screening initiatives, and an increase in the elderly population.

How Will the Oncology Ablation Market Size Evolve and Grow by 2029?
It is projected that the oncology ablation market will experience a significant rise in size in the coming years. The growth rates are expected to reach $2.35 billion by 2029, with a compound annual growth rate of 12.6%. Various factors will contribute to this increase, such as the continuous progression in ablation technology, higher use of the technology in developing countries, a boost in personalized and precise medical treatment, an increase in government support and backing for cancer treatment research and innovation, a heightened request for outpatient procedures, and improved public and professional knowledge. Key trends anticipated during this forecast period encompass the integration of artificial intelligence (AI), enhancements in imaging technologies, robotics-aided ablation, advanced ablation instruments that promote safety, efficacy, and easy use, and the application of telemedicine for pre- and post-ablation care which enables remote monitoring and follow-ups.

View the full report here:
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

What Drivers Are Propelling the Growth of Oncology Ablation Market Forward?
The oncology ablation market is projected to flourish due to a rising number of cancer diagnoses. This involves the utilization of medical tests, imaging, and pathological analysis of tissue to determine the presence of cancer. An increase in cancer diagnoses can be attributed to various factors such as an aging population, enhanced screening programs, increased awareness resulting in early detection, and environmental aspects. The usage of oncology ablation in the treatment of tumors identified in cancer diagnoses offers minimally invasive alternatives to eradicate tumors and enhance the prognosis of patients. For example, the National Cancer Institute reported in May 2024 that about 2,001,140 new cancer cases are anticipated in the United States in 2024, with around 48% of all diagnoses in men consisting of prostate, lung, and colorectal cancers. By 2040, the new cancer instances per year are estimated to jump to 29.9 million, indicating a substantial future rise in cancer occurrences. Moreover, the American Cancer Society, a US-based non-profit committed to raising cancer awareness, noted in June 2022 that approximately 1.9 million new cancer cases were discovered in the USA in 2022. Thus, the escalating number of cancer diagnoses is deemed to fuel the oncology ablation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

Which Emerging Trends Are Transforming the Oncology Ablation Market in 2025?
Leading firms in the oncology ablation market are making significant strides in the development of cutting-edge products such as advanced ablation systems characterized by increased accuracy, embedded imaging technologies for instant direction, and augmented safety functionalities. These advanced systems refer to specialized medical machinery employing high-end technologies to accurately target and eradicate abnormal tissues, such as cancerous growths, while ensuring minimal harm to the surrounding healthy cells. For example, in March 2024, Medtronic Plc, a medical equipment manufacturing firm rooted in Ireland, gained approval from the US Food and Drug Administration for the OsteoCool 2.0, a bone tumor ablation system intended to address painful bone metastases and benign tumors like osteoid osteoma. The updated system possesses notable upgrade features including the capability to operate four internally cooled probes in tandem, thus enabling the ablation of two vertebral bodies simultaneously or the creation of larger ablation zones in non-spinal procedures.

What Are the Key Segments in the Oncology Ablation Market?
The oncology ablation market covered in this report is segmented -

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation
2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:
1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation
2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation
3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation
4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Who Are the Key Players Shaping the Oncology Ablation Market's Competitive Landscape?
Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

What Geographic Markets Are Powering Growth in the Oncology Ablation Market?
North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.